case_images: PMC4943768_01
case_images: Fundus photograph and OCT image of a patient with nAMD in the right eye. a Fundus photograph before the first intravitreal ranibizumab injection showing normal optic disc cupping. b OCT image showing the presence of CNV and SRF.
case_images: cop-0007-0230-g01.jpg
case_images: PMC4943768_01_cop-0007-0230-g01.jpg
case_images: F1
case_images: Two years later, optical coherence tomography (OCT) detected a CNV in his right eye (fig. 1).
case_images: Fundus photograph and OCT image of the same patient with nAMD. a Fundus photograph at 4 weeks after the 25th intravitreal ranibizumab injection, and before the first intravitreal aflibercept injection showing the presence of hard exudates. b OCT image showing the residual SRF and retinal edema.
case_images: cop-0007-0230-g02.jpg
case_images: PMC4943768_01_cop-0007-0230-g02.jpg
case_images: F2
case_images: Because the size of the SRF had not decreased at 4 weeks after the 25th ranibizumab injection, ranibizumab was stopped and the patient was switched to intravitreal aflibercept injections (fig. 2).
case_images: Fundus photograph and OCT image of the same patient with nAMD. a Fundus photograph after trabeculotomy, demonstrating the absence of hard exudates. b OCT image after trabeculotomy showing that both the SRF and the retinal edema have completely disappeared.
case_images: cop-0007-0230-g03.jpg
case_images: PMC4943768_01_cop-0007-0230-g03.jpg
case_images: F3
case_images: Two weeks after surgery, the IOP had decreased to 15 mm Hg without the use of any antiglaucoma medications (fig. 3).